Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 23, Issue 5, 2000, Pages 481-486

  Vallejo, Carlos T ^a,b   Pérez, Juan E ^a   Domínguez, María E ^a   Leone, Bernardo A ^a   Machiavelli, Mario R ^a   Lacava, Juan A ^a   Romero, Alberto O ^a   Ortiz, Eduardo H ^a   Grasso, Sergio ^a   Amato, Sonia ^a   Rodríguez, Ricardo ^a   Barbieri, Mario ^a   Acuña, Juan Romero ^a   Focaccia, Guillermo ^a   Suttora, Guillermo ^a   Scenna, Mirna ^a   Boughen, José M ^a   Acuña, Luis A Romero ^a   Langhi, Mario J ^a  

^a Grupo Oncologico Cooperativo del Sur   (Argentina)

^b GOCS Neuquén ^*  (Argentina)

Author keywords

Cervical cancer; Cisplatin; Ifosfamide; Neoadjuvant chemotherapy; Vinorelbine

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; IFOSFAMIDE; MESNA; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPENIA; MYALGIA; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FEMALE; HUMANS; IFOSFAMIDE; MESNA; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; VINBLASTINE;

EID: 0034442749     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200010000-00010     Document Type: Article

References (44)

1. A possible new trend in the management of carcinoma of the cervix uteri
2. Two-year survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib and II with bulky tumor
3. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: A pilot study
4. Cis dichlorodiamminoplatinum (II) in the treatment of gynecologic malignancies: Phase II trial by the Gynecologic Oncology Group
5. Factors predicting response to chemotherapy and survival in patients with metastatic or recurrent squamous cell cervical carcinoma. A multivariate analysis
6. Cisplatin in advanced cancer of the cervix. An update
7. Neoadjuvant therapy in cancer treatment
8. New approaches to high-risk cervical cancer. Advanced cervical cancer
9. Ifosfamide with Mesna in squamous carcinoma of the cervix. Phase II results in patients with advanced or recurrent disease
10. Combination bleomycin, ifosfamide and cisplatin chemotherapy in cervical cancer
11. Bleomycin, ifosfamide and cisplatin chemotherapy in recurrent and persistent cervical cancer. A prospective study
12. Ifosfamide in experimental tumour systems
13. Phase II studies of bleomycin, ifosfamide and cisplatinum in cervix cancer
14. Combination bleomycin, ifosfamide and cisplatin chemotherapy in cervix cancer
15. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma
16. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer
17. Randomized trial of cisplatinum versus cisplatinum plus mitolactolo, versus cisplatinum plus ifosfamide in advanced squamous carcinoma of the cervix: A Gynaecologic Oncology Group study
18. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma
19. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma
20. Experimental antitumor activity of navelbine
21. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix
22. Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma
23. Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix
24. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: Results of a European multicenter trial including 612 patients
25. Randomized phase III trial of cisplatin (CDDP) vs CDDP plus navelbine (NVB) in treatment of advanced non-small cell lung cancer: Report of a South-West Oncology Group study (SWOG-9308)
26. Phase II study of vinorelbine in heavily previously treated small cell lung cancer
27. Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: Activity in platinum-resistant disease
28. Cisplatin (CDDP), ifosfamide (IFM) with various dosages of vinorelbine (VNB) (NIP) in non resectable non-small cell lung cancer (NIP)
29. Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small cell lung cancer: A phase II study
30. Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CAN) in patients with advanced non-small cell lung cancer (NSCLC): A Fonicap randomized phase II study
31. Reporting results of cancer treatment
32. Five classes of extended hysterectomy for women with cervical cancer
33. Effective prevention of chemotherapy-induced phlebitis by low-dose heparin: A prospective randomized trial
34. Appendix - WHO toxicity guidelines
35. Nonparametric estimation from incomplete observations
36. Exploratory data analysis and the use of the hazard function for interpreting survival data: An investigator's primer
37. The importance of dose intensity in chemotherapy of metastatic breast cancer
38. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes
39. Cisplatin radiation and adjuvant hysterectomy for bulky stage Ib cervical carcinoma
40. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
41. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjuntive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy
42. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer
43. Concurrent chemotherapy and radiation: A major advance for women with cervical cancer
44. Improved treatment for cervical cancer - Concurrent chemotherapy and radiotherapy